Vivo Bio Tech Limited (BOM:511509)
India
· Delayed Price · Currency is INR 27.83
+0.57 (2.09%)
At close: Apr 29, 2026
Vivo Bio Tech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 618 | 583 | 639 | 288 | 566 | 636 | Upgrade
|
| Market Cap Growth | 1.29% | -8.74% | 122.12% | -49.14% | -11.02% | 154.23% | Upgrade
|
| Enterprise Value | 1,170 | 1,148 | 1,225 | 915 | 844 | 885 | Upgrade
|
| Last Close Price | 27.83 | 33.97 | 42.87 | 19.30 | 39.65 | 47.90 | Upgrade
|
| PE Ratio | 11.91 | 8.01 | 25.29 | 10.86 | 25.69 | 11.19 | Upgrade
|
| PS Ratio | 1.20 | 1.25 | 1.41 | 0.55 | 1.10 | 1.23 | Upgrade
|
| PB Ratio | 0.64 | 0.75 | 1.17 | 0.56 | 1.20 | 1.50 | Upgrade
|
| P/TBV Ratio | 0.82 | 1.08 | 1.38 | 0.70 | 1.69 | 2.04 | Upgrade
|
| P/FCF Ratio | - | - | 8.44 | 2.65 | - | - | Upgrade
|
| P/OCF Ratio | - | 4.93 | 4.12 | 1.94 | 3.40 | 4.48 | Upgrade
|
| EV/Sales Ratio | 2.27 | 2.46 | 2.70 | 1.75 | 1.64 | 1.71 | Upgrade
|
| EV/EBITDA Ratio | 6.49 | 6.23 | 6.45 | 4.72 | 5.90 | 5.28 | Upgrade
|
| EV/EBIT Ratio | 10.36 | 9.99 | 10.38 | 7.48 | 10.08 | 7.33 | Upgrade
|
| EV/FCF Ratio | - | - | 16.18 | 8.44 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.58 | 0.69 | 1.34 | 1.20 | 1.43 | 0.73 | Upgrade
|
| Debt / EBITDA Ratio | 3.14 | 2.93 | 3.85 | 3.22 | 4.72 | 1.85 | Upgrade
|
| Debt / FCF Ratio | - | - | 9.65 | 5.76 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.57 | 0.68 | 1.32 | 1.18 | 1.40 | 0.70 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.06 | 2.86 | 3.77 | 3.15 | 4.60 | 1.78 | Upgrade
|
| Net Debt / FCF Ratio | - | -5.05 | 9.47 | 5.63 | -1.91 | -3.45 | Upgrade
|
| Asset Turnover | - | 0.33 | 0.35 | 0.43 | 0.51 | 0.72 | Upgrade
|
| Inventory Turnover | - | 0.74 | 0.50 | 0.80 | 1.01 | 0.61 | Upgrade
|
| Quick Ratio | - | 0.48 | 0.38 | 0.68 | 0.63 | 0.39 | Upgrade
|
| Current Ratio | - | 1.51 | 1.25 | 1.27 | 1.12 | 1.24 | Upgrade
|
| Return on Equity (ROE) | - | 11.01% | 4.75% | 5.35% | 4.91% | 15.04% | Upgrade
|
| Return on Assets (ROA) | - | 5.12% | 5.67% | 6.23% | 5.18% | 10.54% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.79% | 7.41% | 6.14% | 6.21% | 4.45% | 12.37% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 10.00% | 11.90% | 12.50% | 8.40% | 20.90% | Upgrade
|
| Earnings Yield | 7.31% | 12.49% | 3.95% | 9.21% | 3.89% | 8.94% | Upgrade
|
| FCF Yield | - | -17.91% | 11.85% | 37.67% | -60.95% | -13.60% | Upgrade
|
| Buyback Yield / Dilution | -15.62% | 8.33% | -12.53% | -4.66% | -4.44% | -5.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.